1. Home
  2. GEOS vs APLT Comparison

GEOS vs APLT Comparison

Compare GEOS & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEOS
  • APLT
  • Stock Information
  • Founded
  • GEOS 1980
  • APLT 2016
  • Country
  • GEOS United States
  • APLT United States
  • Employees
  • GEOS N/A
  • APLT N/A
  • Industry
  • GEOS Industrial Machinery/Components
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEOS Industrials
  • APLT Health Care
  • Exchange
  • GEOS Nasdaq
  • APLT Nasdaq
  • Market Cap
  • GEOS 72.9M
  • APLT 63.6M
  • IPO Year
  • GEOS 1997
  • APLT 2019
  • Fundamental
  • Price
  • GEOS $17.20
  • APLT $0.43
  • Analyst Decision
  • GEOS
  • APLT Buy
  • Analyst Count
  • GEOS 0
  • APLT 6
  • Target Price
  • GEOS N/A
  • APLT $6.10
  • AVG Volume (30 Days)
  • GEOS 191.3K
  • APLT 876.2K
  • Earning Date
  • GEOS 08-07-2025
  • APLT 11-06-2025
  • Dividend Yield
  • GEOS N/A
  • APLT N/A
  • EPS Growth
  • GEOS N/A
  • APLT N/A
  • EPS
  • GEOS N/A
  • APLT N/A
  • Revenue
  • GEOS $115,527,000.00
  • APLT $121,000.00
  • Revenue This Year
  • GEOS N/A
  • APLT N/A
  • Revenue Next Year
  • GEOS N/A
  • APLT $5,931.24
  • P/E Ratio
  • GEOS N/A
  • APLT N/A
  • Revenue Growth
  • GEOS N/A
  • APLT N/A
  • 52 Week Low
  • GEOS $5.51
  • APLT $0.30
  • 52 Week High
  • GEOS $21.60
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • GEOS 51.00
  • APLT 40.79
  • Support Level
  • GEOS $16.10
  • APLT $0.40
  • Resistance Level
  • GEOS $17.29
  • APLT $0.46
  • Average True Range (ATR)
  • GEOS 1.23
  • APLT 0.03
  • MACD
  • GEOS -0.35
  • APLT -0.01
  • Stochastic Oscillator
  • GEOS 29.37
  • APLT 18.12

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: